Baxter Completes Acquisition of Hillrom

Hillrom Acquires Bardy Diagnostics

January 19, 2021

Medical Devices

Hillrom (NYSE: HRC) agreed to acquire Bardy Diagnostics, Inc. (BardyDx) for $375 million in cash plus potential milestone payments, expanding Hillrom's digital health and ambulatory cardiac monitoring capabilities. The deal brings Hillrom a wearable ECG platform (the CAM patch), approximately $30 million in annualized revenue, and about 230 employees; Hillrom expects the acquisition to be dilutive in year one and accretive thereafter.

Hill-Rom Acquires Voalte for $180M

March 11, 2019

Healthcare Services

Hill-Rom Holdings, Inc. agreed to acquire Voalte, Inc., a Sarasota-based provider of mobile clinical communications, for $180 million in cash plus up to $15 million in commercial milestone payments. The deal adds Voalte's real-time mobile communications platform and large installed base to Hill-Rom's connected care portfolio to advance its digital and mobile communications capabilities.

Hillenbrand Acquires Milacron Holdings Corp.

November 21, 2019

Manufacturing

Hillenbrand, Inc. completed the acquisition of Milacron Holdings Corp. in a cash-and-stock transaction valued at approximately $1.9 billion, with Milacron stockholders receiving cash and Hillenbrand shares. The deal expands Hillenbrand's scale and product portfolio in plastics processing and injection molding, with expected annualized cost synergies of about $50 million within three years.

Audax Private Equity Acquires Aspen Surgical Business Unit from Hillrom

July 10, 2019

Medical Devices

Audax Private Equity has entered into a definitive agreement to acquire Aspen Surgical, a Hillrom business unit that manufactures branded and private-label single-use surgical consumables. Aspen Surgical is headquartered in Caledonia, Michigan with operations in Caledonia and Las Piedras, Puerto Rico, and employs approximately 500 people; the transaction is a divestiture of the surgical consumables business from Hillrom to Audax.

Siemens Healthineers to Acquire Varian Medical Systems

August 2, 2020

Medical Devices

Siemens Healthineers AG has agreed to acquire all shares of Varian Medical Systems, Inc. for USD 177.50 per share, valuing the deal at approximately USD 16.4 billion. The transaction, which aims to create an integrated cancer-care portfolio, is expected to close in H1 2021 subject to Varian shareholder and regulatory approvals.

Amgen Completes Acquisition of Horizon Therapeutics plc

October 6, 2023

Biotechnology

Amgen completed the acquisition of Horizon Therapeutics plc for $116.50 per share in cash, valuing the transaction at approximately $27.8 billion. The deal expands Amgen's inflammation and rare-disease portfolio by adding Horizon's medicines (including TEPEZZA, KRYSTEXXA and UPLIZNA) and strengthens Amgen's biologics R&D, manufacturing and global commercial capabilities.